Parameters of rotational thromboelastometry in patients with moderate and severe psoriasis: a pilot study
- PMID: 40593457
- DOI: 10.1007/s11239-025-03140-z
Parameters of rotational thromboelastometry in patients with moderate and severe psoriasis: a pilot study
Keywords: Hypercoagulation; Psoriasis; Rotational thromboelastometry; Venous thromboembolism.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This research was performed according to ethical standards and was reviewed and approved by the local ethical review board (Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, decision protocol No. EK 68/2020). The patients agreed to participate in this study and signed informed consent for study participation. Competing interests: The authors declare no competing interests.
Similar articles
-
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study.Br J Dermatol. 2025 Mar 18;192(4):618-628. doi: 10.1093/bjd/ljae502. Br J Dermatol. 2025. PMID: 39708367 Clinical Trial.
-
Fumaric acid esters for psoriasis: a systematic review.Ir J Med Sci. 2017 Feb;186(1):161-177. doi: 10.1007/s11845-016-1470-2. Epub 2016 Jun 7. Ir J Med Sci. 2017. PMID: 27271164
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial.Br J Dermatol. 2025 Feb 18;192(3):402-409. doi: 10.1093/bjd/ljae406. Br J Dermatol. 2025. PMID: 39437312 Clinical Trial.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol JEADV 31(2):205–212. https://doi.org/10.1111/jdv.13854 - DOI - PubMed
-
- Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JN (2021) W. N. Psoriasis. Lancet Lond Engl 397(10281):1301–1315. https://doi.org/10.1016/S0140-6736(20)32549-6 - DOI
-
- Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J 31(8):1000–1006. https://doi.org/10.1093/eurheartj/ehp567 - DOI - PubMed
-
- Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN, Gelfand JM (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A Population-Based cohort study. Ann Rheum Dis 74(2):326–332. https://doi.org/10.1136/annrheumdis-2014-205675 - DOI - PubMed
-
- Ahlehoff O, Gislason GH, Lindhardsen J, Charlot MG, Jørgensen CH, Olesen JB, Bretler D-M, Skov L, Torp-Pedersen C, Hansen PR (2011) Psoriasis carries an increased risk of venous thromboembolism: A Danish nationwide cohort study. PLoS ONE 6(3):e18125. https://doi.org/10.1371/journal.pone.0018125 - DOI - PubMed - PMC
LinkOut - more resources
Full Text Sources